Recurrence-Free Survival of a Hepatocellular Carcinoma Patient With Tumor Thrombosis of the Inferior Vena Cava After Treatment With Sorafenib and Hepatic Resection

Sorafenib (Nexabar, Bayer, Berlin, Germany), one of multikinase inhibitors, can infrequently downstage advanced hepatocellular carcinoma (HCC). There are some reports that sorafenib in combination with other modalities, such as transcatheter arterial chemoembolization (TACE) or radiation therapy, co...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int Surg
Autori principali: Nakamura, Kenichi, Beppu, Toru, Hayashi, Hiromitsu, Okabe, Hirohisa, Imai, Kastunori, Nitta, Hidetoshi, Chikamoto, Akira, Ishiko, Takatoshi, Sasaki, Masato, Baba, Hideo
Natura: Artigo
Lingua:Inglês
Pubblicazione: The International College of Surgeons, World Federation of General Surgeons and Surgical Specialists, Inc. 2015
Soggetti:
Hepatobiliary & Pancreatic Surgery
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4452982/
https://ncbi.nlm.nih.gov/pubmed/26011214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9738/INTSURG-D-14-00133.1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi